Identifying and acting on opportunities.
Sectors of Focus
Direct investments where we partner with management or other sponsors
Millicent is a platform created for the purpose of building a global pharma company through the acquisition and development of pharma products.
YEAR: May 2018
PE PARTNER: The Carlyle Group
Tanner Pharma Group is a pharma services company specializing in global patient access and clinical development programs.
SECTOR: Pharma Services
YEAR: January 2011
Covis Pharma is a global pharma company focused on revitalizing deprioritized brands and promoting niche products.
YEAR: December 2011
STATUS: Partially Realized
PE PARTNER: Cerberus Capital Management
iNova is a pharma company that owns and markets a range of prescription and OTC medicines in Australia, South Africa and Asia.
YEAR: October 2017
PE PARTNER: The Carlyle Group & Pacific Equity Partners
Cadence Rx is a PBM that elevates and expands the scope of pharmacy benefit management services available in today’s workers’ compensation market.
YEAR: April 2020
FLEXIBLE + DISCIPLINED
By applying the knowledge gained from our extensive experience, we put insight into action to drive compelling value creation. We have a proven record of creating value for our portfolio companies and investors.
Adding value to our Companies.
ALIGNED + COMMITTED
Alignment with our firm’s focus and values is the cornerstone to generating compelling returns. We invest a significant amount of our own capital and provide investors access to direct or passive co-investments through strong institutional relationships.
Adding value for our Investors.
If you’re seeking opportunities in our sectors of focus, we know what you’re looking for and we know how to find it.